Beryl Drugs
Company Overview - January 14, 2025
Beryl Drugs is a notable player in the Pharmaceuticals - Indian - Bulk Drugs & Formln industry, listed on the BSE (Code: 524606). As of the January 14, 2025, the company holds a market capitalization of INR 17.27 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 34.05, Beryl Drugs has demonstrated a 55.33% return over the last year. Recent performance indicates fluctuations, with a 3.73% change in the past week and a -8.71% change over the last month. The company's all-time high stands at INR 53.00, while its lowest-ever price was INR 0.72.
In terms of sales, Beryl Drugs reported a revenue of INR 22.80 crores, solidifying its position in the market. The average trading volume over the past month has been 4678 shares, with a more recent weekly average of 3644.
With the stock trading below its 50-day moving average of INR 35.92, the company's technical indicators like MACD (-1.22) signal negative trends.
Company Data
| Name | Beryl Drugs |
|---|---|
| BSE Code | 524606 |
| NSE Code | |
| Industry | Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Current Price | 34.05 |
| Market Capitalization | 17.27 |
| Sales | 22.80 |
| Return over 3months | 7.09 |
| Return over 6months | 7.74 |
| Volume 1month average | 4678 |
| Volume 1week average | 3644 |
| Volume | 949 |
| High price | 46.00 |
| Low price | 21.60 |
| High price all time | 53.00 |
| Low price all time | 0.72 |
| Return over 1day | 0.24 |
| Return over 1week | 3.73 |
| Return over 1month | -8.71 |
| Return over 1year | 55.33 |
| Return over 3years | 49.39 |
| Return over 5years | 43.36 |
| Volume 1year average | 13106 |
| DMA 50 | 35.92 |
| DMA 200 | 33.19 |
| DMA 50 previous day | 36.00 |
| DMA 200 previous day | 33.18 |
| MACD | -1.22 |
| MACD Signal | -1.06 |